Orthopedics

Your Article Summary

See Latest Articles

High-grade osteosarcoma of the extremities metastatic to the lung: Long-term results in 323 patients treated combining surgery and chemotherapy, 1985–2005
Surgical Oncology, 06/19/09

Briccoli A et al. - In a study of high-grade osteosarcoma of the extremities metastatic to the lung, it was concluded that in pts with recurrent resectable pulmonary metastases from high-grade osteosarcoma treated with adjuvant or neoadjuvant chemotherapy, thoracotomy should always be considered regardless of the number of previous lung relapses and the number of secondary pulmonary lesions.

• 323 pts, 88 with resectable lung metastases at diagnosis and 235 with localized disease at presentation who relapsed with lung metastases, were treated.

• 498 lung surgeries and 607 thoracotomies were performed.
• 5-yr overall survival was 37%.
• Final outcome was significantly related to presence or absence of metastasis, time of first relapse and presence of local recurrences.
• According to stage of disease, the rate of a 5-yr event-free survival (EFS) was 36% for pts with localized disease who later relapsed and 9% for pts with resectable lung metastases at presentation.
• There were no differences in EFS between pts who underwent 2 or 3 thoracotomies and pts who had 4 or 5 thoracotomies (7.5 vs 18.7%).

Today in Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Prediction model of chemotherapy response in osteosarcoma by 18F-FDG PET and MRI
The Journal of Nuclear Medicine, 08/19/09

Endoprosthetic proximal femur replacement: Metastatic versus primary tumors
Surgical Oncology, 11/05/09

Loss of p16INK4, alone and with overexpression of osteopontin, correlates with survival of patients with spinal metastasis from hepatocellular carcinoma
Medical Oncology, 10/19/09

See All of Oncology